Systane Nighttime mineral oil and white petrolatum 30 mg/g; 940 mg/g Ointment, 1 tube — NDC 00065-0509-35 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Systane Nighttime mineral oil and white petrolatum 30 mg/g; 940 mg/g Ointment, 1 tube — NDC 0065-0509-35 (Billing 00065-0509-35)

by Alcon Laboratories, Inc. · 1 TUBE in 1 CARTON / 3.5 g in 1 TUBE

This is a package of 1 tube of Systane Nighttime mineral oil and white petrolatum 30 mg/g; 940 mg/g Ointment from Alcon Laboratories, Inc., marketed since Jun 2008 and currently FDA-listed; retail pharmacies pay about $2.48 per g (NADAC). It is this product's only package size.

NDC 00065-0509-35
🏷️ FDA NDC (as labeled) 0065-0509-35 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 0065-0509-35 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0065 labeler · 0509 product · 35 package
Package marketed since
Jun 26, 2008
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC)
0300650509350
Medicaid fills, this package
26,682 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0065-0509-35
Product NDC 0065-0509
11-digit billing NDC 00065050935
NCPDP billing unit GM — per gram (weight)
RxCUI 706820
UNII T5L8T28FGP, 4T6H12BN9U
UPC 0300650509350
Application # M018
SPL Set ID 4689c59c-5721-3f91-6c85-e41501998fd0
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2008-06-26
Route OPHTHALMIC
Dosage form OINTMENT
Substance MINERAL OIL; PETROLATUM

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 86209902904220
GPI class Systane Nighttime
GCN Seq No 064246
GCN 99952
HICL code 002215
Ingredient (HICL) Mineral Oil/Petrolatum,White
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q6
Therapeutic class — intermediate (HIC2) Ophthalmic Preparations
HIC3 code Q6Y
Therapeutic class — specific (HIC3) Eye Preparations, Miscellaneous (Otc)
AHFS code 52:92.00.00
AHFS class Eent Drugs, Miscellaneous
FDB label name SYSTANE NIGHTTIME EYE OINTMENT
FDB brand name Systane
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 064246
  • GCN: 99952
  • GPI-14 (Medi-Span): 86209902904220
  • HICL (First Databank): 002215
  • AHFS class code: 52:92.00.00
  • RxCUI (RxNorm): 706820
Why two NDCs? The FDA registers this code as 0065-0509-35 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00065-0509-35. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Softeners, emollients class.

Drug family (ATC) Softeners, emollients
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name SYSTANE NIGHTTIME EYE OINTMENT Ingredient Mineral Oil/Petrolatum,White
🧪 What is this product?

Systane Nighttime is an over-the-counter eye ointment marketed under FDA's OTC drug rules for its category. It contains mineral oil and white petrolatum, which are occlusive lubricants commonly used in nighttime eye products to coat and protect the eye surface. These ingredients are typically used to soothe dry eye discomfort and help retain moisture on the eye overnight.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $2.485 $8.70 / 3.5 g
Medicaid paysCMS SDUD · 12 mo $4.08 $14.29 / 3.5 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Dec 2021 Oct 2022 Mar 2026 Aug 2026 $2.592 $2.210
▲ Up 9% over the last 15 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00065-0509-35 You're viewing this Main listing 1 TUBE in 1 CARTON / 3.5 g in 1 TUBE 2008-06-26 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
GenTeal Tears NIGHT-TIME .03 g/g; .94 g/g 00065-0518-01 Alcon 1 tube $2.480 — Availability likely +0%
Systane Nighttime 30 mg/g; 940 mg/gthis 00065-0509-35 Alcon 1 tube $2.485 — Availability likely —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2008
On the market since
Jun 2008
📍
2026
Currently FDA-listed
18 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 7EV65EAW6H
    Lanolin is a waxy substance derived from sheep's wool. It's used in medicines as an emollient and skin-conditioning agent to soften formulations and improve spreadability in topical products like creams and ointments.

1 inactive ingredient listed in the exact product block matched to this NDC.

The official label also statesanhydrous liquid lanolin 3%

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAlcon Laboratories, Inc.
FDA applicationM018 (OTC MONOGRAPH DRUG)
Labeler code00065
First marketedJun 2008
Product typeHuman Otc Drug
Portfolio55 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 31 words ▾

Uses for the temporary relief of burning and irritation due to dryness of the eye for use as a lubricant to prevent further irritation or to relieve dryness of the eye

⏱️ Dosage and Administration 25 words ▾

Directions Pull down the lower lid of the affected eye and apply a small amount (one-fourth inch) of ointment to the inside of the eyelid.

⚠️ Warnings 18 words ▾

Warnings For external use only Do not use if you are sensitive to any ingredient in this product

🧪 Inactive Ingredients 6 words ▾

Inactive ingredient anhydrous liquid lanolin 3%

🎯 Purpose 11 words ▾

Active ingredients Purpose Mineral Oil 3% Lubricant White Petrolatum 94% Lubricant

📄 When Using This Product 26 words ▾

When using this product remove contact lenses before using do not touch tip of container to any surface to avoid contamination replace cap after each use

📄 Stop Use and Ask a Doctor If 35 words ▾

Stop use and ask a doctor if you are experiencing any of the following: eye pain changes in vision continued redness or irritation of the eye condition worsens or persist for more than 72 hours

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 18 words ▾

Other information Not for use with contact lenses Store at 8° - 27° C (46° - 80° F)

📄 Questions or Comments 8 words ▾

Questions? In the U.S. call 1-800-757-9195 [email protected] www.systane.com

📄 Package Label / Principal Display Panel 196 words ▾

PRINCIPAL DISPLAY PANEL Systane ® LUBRICANT EYE OINTMENT NIGHTTIME SEVERE DRY EYE RELIEF For nighttime protection from further irritation Systane ® LUBRICANT EYE OINTMENT NIGHTTIME SEVERE DRY EYE RELIEF #1 DOCTOR RECOMMENDED BRAND 1 Intensive relief Preservative free OINTMENT Alcon STERILE 3.5 g Tube (1/8 OZ NET WT) TAMPER EVIDENT: For your protection, do not use if carton security seal is damaged or missing at the time of purchase. 1 Based on a survey of eye care professionals. Data on file.

1635970-0623 LOT: EXP.: Systane ® LUBRICANT EYE OINTMENT Alcon Made in Belgium ALCON LABORATORIES, INC. Fort Worth, Texas 76134 USA Systane® LUBRICANT EYE OINTMENT NIGHTTIME SEVERE DRY EYE RELIEF For nighttime protection from further irritation Systane ® LUBRICANT EYE OINTMENT NIGHTTIME SEVERE DRY EYE RELIEF #1 DOCTOR RECOMMENDED BRAND 1 Intensive relief Preservative free OINTMENT Alcon STERILE 3.5 g Tube (1/8 OZ NET WT) TAMPER EVIDENT: For your protection, do not use if carton security seal is damaged or missing at the time of purchase.

1 Based on a survey of eye care professionals. Data on file. 3601179 01-1024 Systane® LUBRICANT EYE OINTMENT Alcon Made in Spain ALCON LABORATORIES, INC.

Fort Worth, Texas 76134 USA

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
26.7K
Units reimbursed last 4 qtrs
119.5K
Gross reimbursed last 4 qtrs
$487.8K
Avg / prescription
$18.28
Avg / unit
$4.0837
Latest quarter Q1 2026
935Rx
Medicaid pays / g
$4.0837
gross reimbursed
vs
NADAC / g
$2.4847
acquisition cost
=
Spread
+$1.5990
+64% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
87% FFS 13% MCO
Fee-for-service · 23,315 Rx Managed care · 3,367 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: 2,132 units · 27.3 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 4,228 units · 73.7 per 100k residents MN Wisconsin: 19,233 units · 325 per 100k residents WI Michigan: 781 units · 7.8 per 100k residents MI New York: 74,106 units · 379 per 100k residents NY Vermont: 420 units · 64.9 per 100k residents VT New Hampshire: no data reported NH Oregon: 56 units · 1.3 per 100k residents OR Nevada: 140 units · 4.4 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 259 units · 8.1 per 100k residents IA Illinois: 2,821 units · 22.5 per 100k residents IL Indiana: 1,906 units · 27.8 per 100k residents IN Ohio: 4,697 units · 39.9 per 100k residents OH Pennsylvania: 1,393 units · 10.7 per 100k residents PA New Jersey: 1,351 units · 14.5 per 100k residents NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 1,463 units · 74.0 per 100k residents NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: 735 units · 8.4 per 100k residents VA Maryland: no data reported MD Connecticut: 795 units · 22.0 per 100k residents CT Rhode Island: 130 units · 11.9 per 100k residents RI Arizona: 896 units · 12.1 per 100k residents AZ New Mexico: 95 units · 4.5 per 100k residents NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: 1,442 units · 20.2 per 100k residents TN North Carolina: no data reported NC South Carolina: 347 units · 6.5 per 100k residents SC Delaware: 39 units · 3.8 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
1.3379
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 379 /100k
2 Wisconsin 325 /100k
3 Nebraska 74.0 /100k
4 Minnesota 73.7 /100k
5 Vermont 64.9 /100k
6 Ohio 39.9 /100k
7 Indiana 27.8 /100k
8 Washington 27.3 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.